03/27/2024 | Press release | Distributed by Public on 03/27/2024 11:03
27 Mar 2024 18:01 CET
BIOMERIEUX
See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo
16165_1240143_PR_bioMrieux_SPOTFIRE_RST_Panel_FDA_Clearance_20240327.pdf
BIOMERIEUX
Les Echos
BIOMERIEUX
FR0013280286
BIM
Euronext